The 1.5-day Gut Microbiome Conference has been conceived to immerse both clinicians and researchers in a comprehensive educational experience, designed to explore how the human microbiome and how altered microbial balance may contribute to chronic disorders such as diabetes/metabolic syndrome, gastrointestinal disorders (IBS, IBD, fatty liver disease), obesity, cancer, and even neurological conditions.

GOAL STATEMENT

To convene a group of researchers, physicians, and other health care professionals with a shared interest in the clinical importance and relevance of modulating the gut microbiome to revolutionize the management of infectious and chronic disease states in which human intestinal microbiota play a critical role. Through the extensive information presented on the pathophysiologic mechanisms of intestinal microbiota, novel detection modalities to assist accurate and timely diagnosis, and therapeutic approaches to manipulating and correcting dysbiosis, participants in the 1.5 day Gut Microbiome Conference will review the most current information emerging from a critical and burgeoning field of research and clinical development.

TARGET AUDIENCE

Gastroenterologists; internists; family practitioners; physician assistants and physicians-in-training with an interest in the pathophysiology, diagnosis, and clinical management of gastrointestinal and a other common diseases.

STATEMENT OF NEED/PROGRAM OVERVIEW

Mounting evidence suggests an active and complex involvement of the intestinal microbiota in common chronic disorders such as diabetes/metabolic syndrome, gastrointestinal disorders (IBS, IBD, fatty liver disease), obesity, cancer, and even neurological conditions. It is also increasingly clear that influencing the gut microbiome has the potential to revolutionize the management of not only infectious diseases, but a broad range of other conditions. Thus, clinicians would benefit from a better appreciation of how microbial-induced inflammation and immunological reactivity may assist in identifying origins of disease, classifying patient subgroups, and individualizing effective treatment strategies.

CME LEARNING OBJECTIVES

Upon completion of this conference, participants should be better able to:

  • Discuss the latest research advances in understanding the gut microbiome as well as practical aspects of interpreting microbiome research and developing a microbiome database
  • Explain the pathophysiologic influence of dysbiosis and microbial metabolism as it relates to the etiology and progression of common diseases, including diabetes, fatty liver disease, cancer, obesity, and gastrointestinal diseases
  • Discuss emerging evidence regarding potential neurologic implications of the gut microbiome
  • Discuss the impact of probiotics on the gut microbiome and the evidence base for their use in managing functional gastrointestinal disorders
  • Discuss the effects of diet on the gut microbiota and its impact on health and human disease
  • Discuss new and emerging concepts regarding the effects of alcohol fermentation, gases, and specific bacterial species on the gastrointestinal lumen and their contribution to gastrointestinal diseases
  • OFF-LABEL DISCLOSURE STATEMENT

    Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.

    LEARNER ASSURANCE STATEMENT

    The University of Cincinnati is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members' significant relationships with drug or device manufacturer(s). The University of Cincinnati is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

    ACCREDITATION STATEMENT FOR JOINTLY PROVIDED ACTIVITY

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and Focus Medical Communications.

    The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

    The University of Cincinnati designates this live activity for a maximum of 10.25 AMA PRA Category 1 Credits™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

    DISCLAIMER STATEMENT

    The opinions expressed during the live activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees' professional development.

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and Focus Medical Communications.

    Provided by the University of Cincinnati and Focus Medical Communications.